Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Human Factors

Date Submitted: Feb 13, 2024
Date Accepted: Jan 15, 2025

The final, peer-reviewed published version of this preprint can be found here:

Usability and User Experience Testing of a Co-Designed Electronic Patient-Reported Outcomes App (“MyPal for Adults”) for Palliative Cancer Care: Mixed Methods Study

Bonotis P, Angelidis P, Natsiavas P

Usability and User Experience Testing of a Co-Designed Electronic Patient-Reported Outcomes App (“MyPal for Adults”) for Palliative Cancer Care: Mixed Methods Study

JMIR Hum Factors 2025;12:e57342

DOI: 10.2196/57342

PMID: 40278640

PMCID: 12045520

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Usability and User Experience Testing of “MyPal for adults” a Co-Designed Electronic Patient-Reported Outcomes (ePROs) app for Adults with Hematologic Malignancies: A Mixed Methods Study

  • Panos Bonotis; 
  • Pantelis Angelidis; 
  • Pantelis Natsiavas

ABSTRACT

Background:

Mobile health (mHealth) technologies have the potential to enhance cancer patient management, communication, and overall quality of life. The MyPal project, employing a participatory design approach, aims to provide palliative care support for patients with hematological malignancies through an electronic patient-reported outcomes (ePROs) eHealth platform.

Objective:

To evaluate the usability and user experience of "MyPal for adults," a co-designed palliative care mobile app intended to support adult patients affected by hematologic malignancies.

Methods:

Representative users participated in a 4-step usability study employing a think-aloud protocol, complimented with feature satisfaction, difficulty perceived, and design impression surveys along with a short semi-structured interview. Participants were also asked to provide qualitative feedback via the post-use System Usability Scale (SUS), User Experience Questionnaire (UEQ), and Post-study System Usability Questionnaire (PSSUQ). The data were analyzed along the lines of the ISO 9241-210 framework.

Results:

All participants found the intervention content useful, and they reported satisfactory usability, with a mean PSSUQ score of 2.458 and a SUS score of 68.9%. All aspects of the UEQ (Attractiveness, Perspicuity, Efficiency, Dependability, Stimulation, Novelty) surpassed usability quality benchmarks. Identified usability issues primarily related to effectiveness and efficiency as defined in ISO 9241-210.

Conclusions:

In this study, we conducted a comprehensive usability evaluation of the MyPal for Adults app, a digital tool designed to enhance the palliative care experience. This approach identifies real-world usability issues, enabling iterative improvements in the eHealth platform's design. Our findings reveal a user-friendly interface and positive patient experiences. This study emphasizes the need to enhance palliative care mHealth platform usability, offering insights to improve palliative care for cancer patients.


 Citation

Please cite as:

Bonotis P, Angelidis P, Natsiavas P

Usability and User Experience Testing of a Co-Designed Electronic Patient-Reported Outcomes App (“MyPal for Adults”) for Palliative Cancer Care: Mixed Methods Study

JMIR Hum Factors 2025;12:e57342

DOI: 10.2196/57342

PMID: 40278640

PMCID: 12045520

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.